Meeting Report on an Integrated Research Agenda for Mosquito-Borne Arboviruses - Scorecard - MDSpire

Meeting Report on an Integrated Research Agenda for Mosquito-Borne Arboviruses

  • By

  • Angela K Ulrich

  • Nicolina M Moua

  • Alison Mack

  • Natsuko Imai-Eaton

  • J Erin Staples

  • Angela J Mehr

  • Julia T Ostrowsky

  • Tabitha Leighton

  • Ana Cehovin

  • Petra C Fay

  • Josephine P Golding

  • Emma Maynard

  • Luke Alphey

  • Diana P Rojas Alvarez

  • Lark L Coffey

  • Nuno R Faria

  • Rafael Maciel-de-Freitas

  • Kevin Maringer

  • Kris A Murray

  • Henrik Salje

  • Rosemary Sang

  • Pedro F C Vasconcelos

  • Yee-Sin Leo

  • Steven P Sinkins

  • Jocelyne Neto de Vasconcelos

  • Samuel K Dadzie

  • Eva Harris

  • Thais H dos Santos

  • Raman Velayudhan

  • Jurai Wongsawat

  • Michael T Osterholm

  • Eve M Lackritz

  • July 9, 2025

  • 0 min

Share

Clinical Scorecard: Summary of a Collaborative Research Framework for Arboviruses Transmitted by Mosquitoes

At a Glance

CategoryDetail
ConditionMosquito-borne arbovirus (MBV) diseases including Dengue, chikungunya, yellow fever, and Zika
Key MechanismsTransmission primarily by Aedes mosquito species (Ae. aegypti and Ae. albopictus) influenced by ecological, economic, and social factors such as climate change, urbanization, and vector control limitations
Target PopulationGlobal populations living in endemic and emerging areas, particularly in the Americas, Africa, and Asia
Care SettingPublic health and epidemic preparedness settings including academic, governmental, and global health organizations

Key Highlights

  • Rapid expansion of MBV diseases driven by climate change, urbanization, global travel, poverty, and insufficient vector control
  • Significant increase in Dengue incidence with nearly half the world’s population at risk and record outbreaks in the Americas
  • Integrated multipathogen research and policy approaches are essential for effective MBV disease prevention, preparedness, and control

Guideline-Based Recommendations

Diagnosis

  • Utilize surveillance and early detection strategies to monitor MBV transmission and outbreaks
  • Incorporate multipathogen approaches to improve diagnostic accuracy and epidemic preparedness

Management

  • Implement integrated vector control programs targeting primary vectors Ae. aegypti and Ae. albopictus
  • Leverage existing knowledge and systems to address social and ecological drivers of MBV transmission

Monitoring & Follow-up

  • Enhance global surveillance systems for early detection and monitoring of MBV spread
  • Employ evolutionary and viral adaptation studies to anticipate changes in disease burden and transmission

Risks

  • Recognize increased risk due to climate change, urbanization, and global travel facilitating vector expansion
  • Address deficiencies in water storage, sanitation, and vector control that contribute to outbreak severity

Patient & Prescribing Data

Populations in endemic and emerging MBV transmission areas, including vulnerable groups in urban and rural settings

Focus on prevention through vector control and vaccination where available; clinical management guided by disease severity and outbreak context

Clinical Best Practices

  • Adopt integrated, multipathogen surveillance and research frameworks to improve epidemic preparedness
  • Prioritize research and investment in social, ecological, and vector control factors influencing MBV disease dynamics
  • Collaborate across sectors including academia, government, NGOs, and industry for comprehensive MBV control strategies

References

Original Source(s)

Related Content